Welcome to the e-CCO Library!

P003 Metabolomics for improved patient stratification in inflammatory bowel disease: Characterisation of the ulcerative colitis metabolome
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Diab1, T. Hansen1, R. Goll2,3, H. Stenlund4, E. Jensen1, T. Moritz4,5, J. Florholmen2,3, G. Forsdahl1

Created: Thursday, 30 January 2020, 10:12 AM
P0030: Multiomic Analysis Reveals Three Distinct subtypes within Perianal Crohn’s Diseasex7x7x7 Independent of Concomitant Proctitis
Year: 2025
Source: ECCO'25
Authors: Abdurahimanx7x7x7 S.(1)*;Sabinox7x7x7 J.(1x7x7x72);Verstocktx7x7x7 S.(1);Ferrantex7x7x7 M.(1x7x7x72);Lenfantx7x7x7 M.(1x7x7x72);Raesx7x7x7 J.(3x7x7x74);D’Hoorex7x7x7 A.(5x7x7x76);Vermeirex7x7x7 S.(1x7x7x72);Bislenghix7x7x7 G.(5);Verstocktx7x7x7 B.(1x7x7x72);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0031: The role of LAT1 in colitis and colitis-associated tumourigenesis
Year: 2025
Source: ECCO'25
Authors: Suix7x7x7 Y.(1)*;Okamotox7x7x7 N.(2);Hoshi*x7x7x7 N.(2);Inouex7x7x7 Y.(2);Funatsux7x7x7 T.(3);Kux7x7x7 Y.(2);Ooix7x7x7 M.(2);Watanabex7x7x7 D.(2);Miyazakix7x7x7 H.(2);Agawax7x7x7 M.(2);Nakamurax7x7x7 H.(2);Yangx7x7x7 H.(1);Kodama x7x7x7 Y.(2);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0032: Human Extrachromosomal Circular DNA (EccDNA) is a Novel Biomarker in Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Di Vincenzox7x7x7 F.(1)*;Petitox7x7x7 V.(2);Gerovskax7x7x7 D.(3);Piazzesix7x7x7 A.(4);Russox7x7x7 A.(5);Turchinix7x7x7 L.(6);Masix7x7x7 L.(2);Lopetusox7x7x7 L.R.(6);Regenbergx7x7x7 B.(7);Gasbarrinix7x7x7 A.(8);Putignanix7x7x7 L.(5);Aruzo-Bravox7x7x7 M.J.(9);Scaldaferrix7x7x7 F.(10);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0033: GPR84x7x7x7 which is increased in Ulcerative Colitis patientsx7x7x7 regulates the cytokine secretion of macrophages
Year: 2025
Source: ECCO'25
Authors: Cejudo-Garcésx7x7x7 A.(1)*;Patelx7x7x7 J.(1);Jarénx7x7x7 A.(1);Macias-Cejax7x7x7 D.(1);Navarro-Vicentex7x7x7 F.(2);Calatayudx7x7x7 S.(1x7x7x73);Barrachinax7x7x7 M.D.(1x7x7x73);Ortiz-Masiáx7x7x7 D.(3x7x7x74x7x7x75);Cosín-Rogerx7x7x7 J.(1x7x7x73);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0034: Glycosylation as new molecular mechanism underlying Pediatric Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Amorimx7x7x7 R.(1x7x7x72x7x7x73)*;Santos-Pereirax7x7x7 B.(2x7x7x73);M. Diasx7x7x7 A.(2);Sousa Pintox7x7x7 B.(3x7x7x74x7x7x75);J. Lefeberx7x7x7 D.(6x7x7x77);Espinheirax7x7x7 C.(1x7x7x78);Trindadex7x7x7 E.(1x7x7x78);Carneirox7x7x7 F.(3x7x7x79x7x7x710);Gaifemx7x7x7 J.(2);Pinhox7x7x7 S.(2x7x7x73x7x7x711);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0035: Food compounds associated with disease activity in Inflammatory Bowel Disease: a novel approach
Year: 2025
Source: ECCO'25
Authors: Meimax7x7x7 M.(1x7x7x72)*;Westerhoutx7x7x7 J.(1);Meijerinkx7x7x7 M.(1);Bijlsmax7x7x7 S.(1);van Schaikx7x7x7 F.(2);Oldenburgx7x7x7 B.(2);Houben x7x7x7 G.(1x7x7x73);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0036: NRG1x7x7x7 a gene significantly detected from intestinal mucosa eccDNAx7x7x7 may predict therapeutic response in Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Emolix7x7x7 V.(1);Foscarinix7x7x7 E.(1)*;Di Vincenzox7x7x7 F.(2x7x7x73);Masix7x7x7 L.(1);Troisix7x7x7 S.(1x7x7x74);Panex7x7x7 C.(1x7x7x74);Migliorex7x7x7 G.(1);Piazzesix7x7x7 A.(5);Turchinix7x7x7 L.(3);Pugliesex7x7x7 D.(3);Laterzax7x7x7 L.(3);Lopetusox7x7x7 L.R.(2x7x7x74x7x7x76);Papax7x7x7 A.(2x7x7x73);Cammarotax7x7x7 G.(2x7x7x77);Putignanix7x7x7 L.(5);Gasbarrinix7x7x7 A.(1x7x7x72x7x7x73);Scaldaferrix7x7x7 F.(1x7x7x72x7x7x73);Petitox7x7x7 V.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0037: ATF7 Deficiency Exacerbates Mitochondrial Dysfunction and Intestinal Inflammation in Ulcerative Colitis
Year: 2025
Source: ECCO'25
Authors: Chenx7x7x7 Y.(1)*;Liangrux7x7x7 Z.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0038: Perianal Fistula Closure after Heterologous Mesenchymal Stem Cell Injections is Associated with Protein Levels indicating Lower Tissue Immune Infiltratex7x7x7 Specific Proteins Involved in the Control of Apoptosisx7x7x7 and Probable Higher Tissues Remodeling and Proteasome Activity
Year: 2025
Source: ECCO'25
Authors: Meuwisx7x7x7 M.A.(1x7x7x72)*;Baiwirx7x7x7 D.(3);Fleronx7x7x7 M.(4);Mazzucchellix7x7x7 G.(4x7x7x75);Boutaffalax7x7x7 L.(6);Reenaersx7x7x7 C.(6);Van Kemsekex7x7x7 C.(6);Vieujeanx7x7x7 S.(6x7x7x77x7x7x78);Bettonvillex7x7x7 V.(9);Briquetx7x7x7 A.(10);Lechanteurx7x7x7 C.(11);Coimbra Marquesx7x7x7 C.(12);Louisx7x7x7 E.(6x7x7x713);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0039: Deletion of the autophagy-related gene 16 like 1 (Atg16l1) in the myeloid lineage induces systemic inflammation
Year: 2025
Source: ECCO'25
Authors: Wobbex7x7x7 M.(1)*;Falk-Paulsenx7x7x7 M.(1);Luziusx7x7x7 A.(1);Pimenta Bernardesx7x7x7 J.(1);Kimmigx7x7x7 F.(1);Rosenstielx7x7x7 P.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P003: Activation of endoplasmic reticulum stress in the intestinal mucosa of Crohn’s disease patients
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Coope*1, J. D. Botezelli2, M. L. S. Ayrizono1, L. A. Velloso3, 
R. F. Leal1

Created: Friday, 22 February 2019, 9:49 AM
P003: C86/CD16 macrophages may act as a source of WNT2b in intestinal tissue from B3 Crohn’s disease patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

D. Ortiz-Masia1,2, J. Cosin-Roger2,3, M. Rodriguez-Antequera1, D. Macias-Ceja3, S. Coll4, P. Salvador4, L. Gisbert-Ferrándiz4, R. Alós5, J. Manyé6, F. Navarro-Vicente7, S. Calatayud2,4, M. D. Barrachina2,4

Created: Friday, 22 February 2019, 9:41 AM
P003: HDAC7 Controls Differentiation and Regeneration in the Intestinal Epithelium
Year: 2021
Source: ECCO'21 Virtual
Authors: Gerbeth, L.(1);Glauben, R.(1);Siegmund, B.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P003: Identification of a novel therapeutic agent for treating Crohn’s disease guided by systems medicine
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Burkitt1,2*, K. Lloyd1, S. Papoutsopopoulou1,3, E. Smith3, A. Kel4, P. Stegmaier4, W. Müller3, C. Probert1,2, The SysmedIBD Consortium

Created: Thursday, 21 February 2019, 9:14 AM
P003: Identification of an intestine-derived ex-Trm population in the blood of healthy individuals and patients with Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Rodger, B.(1);Gordon, H.(1);Hoti, I.(1);Stagg, A.(1);Lindsay, J.(1);
Created: Friday, 11 February 2022, 3:52 PM
P003: MicroRNAs as biomarkers in Inflammatory Bowel Disease unclassified (IBDU) patient samples may predict the development from IBDU to Crohn's Disease or Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Pallikkunnath James, J.(1)*;Riis, L.B.(1,2);Malham, M.(3,4);Høgdall, E.(1,2);Langholz, E.(2,5);Nielsen, B.S.(6);
Created: Friday, 14 July 2023, 10:43 AM
P004 PN-943, an oral α4β7 integrin antagonist, inhibits MAdCAM1-mediated proliferation and cytokine release from CD4+ T cells independent of trafficking
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. CHENG, S. Venkataraman, L. Zhao, L. Lee, T. Tang, D. Liu, L. Mattheakis

Created: Thursday, 30 January 2020, 10:12 AM
P0040: Measurement of collagen concentration throughout the intestinal layers using Deep Learning: implications in Inflammatory Bowel Disease (IBD)
Year: 2025
Source: ECCO'25
Authors: Tsounisx7x7x7 E.(1)*;Forlanox7x7x7 R.(2);Voulgarisx7x7x7 T.(3);Bosganax7x7x7 P.(4);Tsakaix7x7x7 O.(5);Giannakeasx7x7x7 N.(5);Kalafatelix7x7x7 M.(1);Aggeletopouloux7x7x7 I.(1);Pastrasx7x7x7 P.(1);Diamantopouloux7x7x7 G.(1);Tsoliasx7x7x7 C.(1);Melachrinoux7x7x7 M.(4);Thomopoulosx7x7x7 K.(1);Theocharisx7x7x7 G.(1);Tzallasx7x7x7 A.(5);Goldinx7x7x7 R.(6);Manousoux7x7x7 P.(2);Triantosx7x7x7 C.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0041: Assessment of real-world effectiveness of risankizumab in patients with moderate-severe Crohn’s disease in a global setting
Year: 2025
Source: ECCO'25
Authors: Dignassx7x7x7 A.(1)*;Joshix7x7x7 N.(2);Lukanovax7x7x7 R.(3);Dawodx7x7x7 F.(3);Jonesx7x7x7 W.(3);Kligysx7x7x7 K.(2);Zambranox7x7x7 J.A.(2);Songx7x7x7 A.(2); Griffithx7x7x7 J.(2);Jairathx7x7x7 V.(4);Bossuytx7x7x7 P.(5);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session